Orlistat produces modest but meaningful weight loss. In clinical trials, people taking the prescription dose (120 mg three times daily) lost an average of about 8.8 kg (roughly 19 pounds) over one year, compared to 5.8 kg (about 13 pounds) with a placebo. That extra 3 kg difference may sound small, but it comes with measurable improvements in cholesterol, blood pressure, and blood sugar control that matter for long-term health.
How Orlistat Works
Orlistat blocks roughly 30% of the fat you eat from being absorbed. It does this by disabling the enzymes in your gut that normally break down dietary fat. Instead of entering your bloodstream, that undigested fat passes through your digestive tract and leaves your body in your stool. The drug doesn’t suppress appetite, speed up your metabolism, or affect any other nutrients. It only targets fat.
Because it works locally in the gut rather than in the brain or bloodstream, orlistat has a different side effect profile than most other weight loss medications. It also means the drug is only useful if your diet contains fat to block. If you eat a very low-fat meal, there’s little for orlistat to act on.
Weight Loss in Clinical Trials
The best evidence comes from large randomized trials lasting one to two years. In a major study published in JAMA, participants on the prescription dose lost an average of 8.76 kg over the first year, while those on placebo lost 5.81 kg. Both groups also followed a reduced-calorie diet, which is important context: orlistat adds to the effect of dieting, it doesn’t replace it. The roughly 3 kg of additional weight loss over a year is consistent across multiple trials.
An over-the-counter version (sold as Alli) contains 60 mg per capsule, half the prescription strength. It blocks less fat and produces smaller weight loss, typically a few extra pounds beyond diet alone. The prescription version, marketed as Xenical, is the one tested in most clinical research.
Weight loss with orlistat tends to plateau around six to nine months. In two-year studies, some weight regain occurred in the second year, though people who continued taking the drug generally kept off more weight than those switched to placebo. Like all weight loss medications, orlistat works best as part of sustained dietary changes rather than as a short-term fix.
Benefits Beyond the Scale
For people with type 2 diabetes, orlistat improves blood sugar control beyond what weight loss alone would predict. In a study of overweight and obese patients already taking metformin, those who added orlistat saw their HbA1c (a measure of average blood sugar over three months) drop by 0.90 percentage points, compared to 0.61 points with placebo. A significantly larger proportion of the orlistat group achieved clinically meaningful HbA1c reductions of 0.5% or more.
The same trial found that orlistat users had greater decreases in total cholesterol, LDL (“bad”) cholesterol, and systolic blood pressure compared to placebo. These improvements matter because the conditions orlistat treats, obesity and type 2 diabetes, carry elevated cardiovascular risk. Even modest shifts in cholesterol and blood pressure add up over years.
Gastrointestinal Side Effects
The side effects of orlistat are directly tied to how it works. When undigested fat reaches the lower intestine, it can cause oily or fatty stools, oily spotting on underwear, excessive gas, bloating, and urgent bowel movements. Between 16% and 40% of users experience at least one of these effects. Fecal incontinence, the most distressing side effect, occurs in about 7% of patients.
These effects tend to be worst in the first few weeks and often improve as people learn to adjust their fat intake. Eating a high-fat meal while taking orlistat almost guarantees unpleasant digestive symptoms, which some people actually find useful as a built-in deterrent against fatty foods. Spreading your fat intake evenly across meals rather than loading it into one sitting also helps. A general guideline is to keep each meal to about 15 to 20 grams of fat.
Because orlistat blocks fat absorption, it also reduces absorption of fat-soluble vitamins: A, D, E, and K. Taking a daily multivitamin containing these nutrients is recommended, ideally at bedtime or at least two hours before or after your orlistat dose so the vitamin has a chance to be absorbed without interference.
How It Compares to Other Options
Orlistat produces less weight loss than newer medications like semaglutide (Wegovy) or tirzepatide (Mounjaro), which typically lead to 15% or more of body weight lost in trials. It also produces less weight loss than older options like phentermine-topiramate. Where orlistat stands out is its safety profile and accessibility. It has been on the market since 1999, has a long track record, works only in the gut, and the lower-dose version is available without a prescription.
For someone looking for dramatic weight loss, orlistat is not the most powerful tool available. For someone who wants a low-risk addition to a structured diet, particularly if they have cholesterol or blood sugar concerns, it fills a specific niche. The 5% to 10% total body weight loss that most users achieve is enough to produce real metabolic benefits, even if it doesn’t transform someone’s appearance.
What Makes Orlistat Work Better
The people who get the most out of orlistat are those who commit to a reduced-calorie, moderate-fat diet alongside the medication. In trials, both the drug group and the placebo group followed the same diet plan, and the placebo group still lost a meaningful amount of weight. Orlistat amplifies the effect of dietary changes rather than creating results on its own.
Consistency matters too. The drug is taken with each main meal that contains fat, three times a day. Skipping doses or taking it only sporadically reduces its effectiveness. If a meal contains no fat, you can skip that dose since there’s nothing for the drug to block. Exercise wasn’t a controlled variable in most orlistat trials, but physical activity independently improves the metabolic markers (blood sugar, blood pressure, cholesterol) that orlistat also targets, so combining the two makes practical sense.